Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Modra Pharmaceuticals B V has 1 pending office action in its patent portfolio. This action is being reviewed by 1 distinct examiner, HAVLIN, ROBERT H. The portfolio shows 0 distinct art units. This indicates a singular focus for the company's current prosecution, with all activity centered on one examiner and one pending matter.
HAVLIN, ROBERT H is the busiest examiner, managing 1 pending office action. As the only examiner involved, HAVLIN, ROBERT H has total oversight of the portfolio's active prosecution. Practitioners can focus their efforts on the specific examination patterns of this individual. The data showing 0 distinct art units suggests a streamlined administrative process for the current pending application. This concentration allows for a very specific and focused prosecution strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAVLIN, ROBERT H | 1 | 51.5% | +28.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18838206 | METHODS AND COMPOSITIONS FOR TREATING CANCER IN TAXANE-RESISTANT PATIENTS | HAVLIN, ROBERT H | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18838206 | METHODS AND COMPOSITIONS FOR TREATING CANCER IN TAXANE-RESISTANT PATIENTS | HAVLIN, ROBERT H | — | §102§103DP | Non-Final OA | — | Pending | Aug 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial